Senior Management

The Pharmaceutical Management Service Team at Dow Pharmaceutical Sciences:

Bhaskar Chaudhuri, Ph.D.

President

Dr. Chaudhuri has a doctorate in physical pharmacy, an M.S. in industrial pharmacy and a B.S. in pharmacy. He has over 20 years experience in pharmaceutical management service, research and development.

Prior to joining Dow, Dr. Chaudhuri served as Executive Vice President of Scientific Affairs for Bertek Pharmaceuticals, a subsidiary of Mylan Laboratories, with responsibility for research and development for cardiology, neurology and dermatology as well as manufacturing areas of the company.

Prior to this he was the General Manager of the dermatology division of Mylan Labs. From 1992 to 1998 he worked for Penederm Inc., a dermatology company acquired by Mylan, where he was intimately involved in the development of several dermatology products.

While at Penederm, Dr. Chaudhuri held several positions including that of Vice President of Pharmaceutical Sciences.

Gordon Dow, Pharm. D.

Founder & Chief Technical Officer

For almost 30 years, Dr. Gordon Dow has been spearheading the organization's evolution into an internationally recognized, topical product development company.

Prior to founding Dow Dermatologics in 1977, Gordon served as Vice President of Research and Development at Ingram Pharmaceuticals; a company later acquired by Syntex, where he developed seven commercially successful products, including four dermatologicals.

Dr. Dow holds a doctorate in pharmacy from the University of California in San Francisco. Gordon's keen sense of balance between science and business has been a key component in Dow’s service and has been a cornerstone in the added value in pharmaceutical management services and products that we provide our customers.

Darlene Walley, Ph.D.

General Manager

Dr. Darlene Walley is General Manager of Dow Pharmaceutical Sciences.  She has over 25 years experience in the consumer and health care product fields and holds Ph.D. and B.A. degrees in Chemistry.

Dr. Walley has helped develop hundreds of products, holds twelve patents and authored or contributed to many publications.  She has served as an executive at Procter & Gamble, Gillette and Arm & Hammer and most recently as CEO of early stage companies such as Dr. Michelle Copeland Skin Care and OraPro, Inc.  Dr. Walley was CEO of Cooke Pharma which later became a division of United Therapeutics. 

She was Executive Vice President and Chief Operating Officer at Hill Top Research, a full service CRO.  Dr. Walley has expertise in personal care, cosmetic, OTC and Rx product companies ranging from start-up groups to Fortune 500 companies.

Barry Calvarese, B.A., M.S.

Vice President, Clinical & Regulatory Affairs

Barry oversees regulatory approval strategies, marketing authorization submissions, and clinical trial design and implementation for Dow Pharmaceutical Sciences, Inc.. He brings to the company 25 years of experience in the dermatological, pharmaceutical, biotechnology and medical-device product development and approval fields. Barry was formerly Vice President of Regulatory, Clinical and Quality for Fibrogen, Inc. He also served as Executive Director of Regulatory and Clinical affairs for Penederm Inc., a dermatology company, where he gained extensive hands-on experience in managing the approval of three new topical dermatological prescription drugs. Barry also has substantial regulatory and clinical affairs experience with other companies including Progressive Angioplasty Systems, Collagen Corporation, Advanced Surgical Intervention, Pfizer and the UCLA School of Medicine. He holds an M.S. in epidemiology and a B.A. in psychology from UCLA.